Prior Movesmirror the world’s best investors
Preview. Tables on this page show their first five rows. Sign in if you subscribe, or see what Pro includes.

MSGS: who owns it, and who’s predicted to buy next

Madison Square Garden Sports · Unknown · on the Prior Moves forward board for 2026-09-30 at rank #105. Research, not investment advice.

73 PriorScorelast close $402.303m momentum 4.2%

Predicted to buy next quarter

3 tracked investors are included in the model-ranked expectations for MSGS in 2026-09-30. This is a forecast about a later filing, not a confirmation that anyone has bought the security or a recommendation to do so.

Strongest ranked investor signal: George Soros. No calibrated purchase probability is shown.

Currently disclosed holders

From the most recent 13F books we track, 1 investor discloses a position in MSGS (weight = share of that investor’s US equity book). A 13F can be up to 45 days stale.

InvestorBook weight
Ariel2.6%

Mutual fund and ETF holders

157 US mutual funds and ETFs from 84 fund families reported a position in MSGS for the quarter ending 2026-06-30. Against their own report a quarter earlier, 38 raised shares, 27 opened a new position, 52 cut and 10 sold out. Source: SEC Form N-PORT, which funds file about 60 days after quarter end. Share counts, not trades: a change can reflect fund inflows rather than a decision about MSGS.

Fund familyFundsShare of fund-held shares
Ishares Trust1226.9%
Vanguard Index Funds425.6%
Spdr Series Trust75.1%
Ariel Investment Trust34.8%
T. Rowe Price Capital Appreciation Fund, Inc.13.8%
Eq Advisors Trust103.6%
T. Rowe Price Small-Cap Value Fund, Inc.13.3%
T. Rowe Price Small-Cap Stock Fund, Inc.13.2%
The weekly digest

The predicted next buys, fresh disclosures, and the week’s catalysts. One email a week. Honest numbers, never advice.

See the full ranked board on top picks, how the PriorScore is built on how it works, the honest edge numbers on methodology, and the running accuracy on the prediction leaderboard. Forward quarter 2026-09-30, data as of 2026-10-16. Research, not investment advice, see the disclaimer.